Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: an Analysis of 904 Patients with 7882 Person-Years of Follow-Up.
Kiemen AL, Young ED, Blackford AL, Wu P, Burkhart RA, Burns WR, Cameron JL, Lafaro K, Shubert C, Gaillard Z, Ebong UA, Reucroft I, Shen Y, Dequiedt L, Matos V, Klöppel G, Kasajima A, He J, Hruban RH. Kiemen AL, et al. Among authors: lafaro k. Endocr Pathol. 2025 Jun 27;36(1):24. doi: 10.1007/s12022-025-09866-z. Endocr Pathol. 2025. PMID: 40576906 Free PMC article.
ASO Visual Abstract: Survival Outcomes and Genetic Characteristics of Resected Pancreatic Acinar Cell Carcinoma.
Blair AB, Radomski SN, Chou J, Liu M, Howell TC, Park W, O'Reilly EM, Zheng L, Balachandran VP, Wei AC, Kingham TP, D'Angelica MI, Drebin J, Zani S, Blazer D 3rd, Burkhart RA, Burns WR 3rd, Lafaro KJ, Allen PJ, Jarnagin WR, Lidsky ME, He J, Soares KC. Blair AB, et al. Among authors: lafaro kj. Ann Surg Oncol. 2025 Jun 18. doi: 10.1245/s10434-024-16439-7. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40531404 No abstract available.
The Mutational Status of Driver Genes in Patients with Resected Pancreatic Ductal Adenocarcinoma is Associated with Pathological Characteristics and Overall Survival.
Campbell BA, Solinas D, Blackford AL, Dal Molin M, Purchla J, McPhaul T, Chidambaram S, Cameron JL, Lin MT, Hruban RH, Shubert CR, Lafaro KJ, Burkhart RA, Burns WR, He J. Campbell BA, et al. Among authors: lafaro kj. Ann Surg. 2025 Jun 18. doi: 10.1097/SLA.0000000000006794. Online ahead of print. Ann Surg. 2025. PMID: 40528743
ASO Visual Abstract: Association Between Adjuvant Therapy and Survival in Resected Pancreatic Ductal Adenocarcinoma After Different Types and Durations of Neoadjuvant Therapy.
Andel PCM, Campbell BA, Habib JR, Molenaar IQ, Lafaro KJ, Burns WR 3rd, Daamen LA, Cameron JL, Wolfgang CL, Burkhart RA, He J, Javed AA. Andel PCM, et al. Among authors: lafaro kj. Ann Surg Oncol. 2025 Jun 4. doi: 10.1245/s10434-025-17570-9. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40468137 No abstract available.
Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: An Analysis of 904 Patients with 7882 Person-Years of Follow-Up.
Kiemen AL, Young ED, Blackford AL, Wu P, Burkhart RA, Burns WR, Cameron JL, Lafaro K, Shubert C, Gaillard Z, Ebong UA, Reucroft I, Shen Y, Dequiedt L, Matos V, Klöppel G, Kasajima A, He J, Hruban RH. Kiemen AL, et al. Among authors: lafaro k. medRxiv [Preprint]. 2025 Apr 3:2025.04.01.25325055. doi: 10.1101/2025.04.01.25325055. medRxiv. 2025. PMID: 40236435 Free PMC article. Preprint.
Carbohydrate Antigen 19-9 Delta Function for Survival Prediction in Borderline Pancreatic Cancer. A PANC-PALS Consortium International Multicenter Derivation and Validation Study.
Garnier J, Marchetti A, Campbell B, Andel PCM, Alfano MS, Hidalgo Salinas C, Traversari E, Habib JR, Lionetto G, Palen A, Ewald J, Lafaro K, Hewitt DB, Burkhart RA, Paiella S, Sacks GD, Malleo G, Wolfgang CL, Salvia R, He J, Turrini O, Javed AA. Garnier J, et al. Among authors: lafaro k. Ann Surg. 2025 Apr 16. doi: 10.1097/SLA.0000000000006735. Online ahead of print. Ann Surg. 2025. PMID: 40235433
Neoadjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasm-derived Pancreatic Cancer.
Habib JR, Rompen IF, Javed AA, Campbell BA, Kinny-Köster B, Tan PH, Miller RM, Pellegrini R, Marchetti A, Andel PCM, Perri G, Lafaro KJ, Hewitt DB, Kaiser J, Daamen LA, Hank T, Sacks GD, Billeter AT, Morgan K, Busch OR, Müller-Stich BP, Marchegiani G, Ven Fong Z, Molenaar IQ, Besselink MG, Büchler MW, Wolfgang CL, He J, Loos M. Habib JR, et al. Among authors: lafaro kj. Ann Surg. 2025 Mar 5. doi: 10.1097/SLA.0000000000006687. Online ahead of print. Ann Surg. 2025. PMID: 40042799
Implications of Neoadjuvant Therapy on Prognostic Factors in Pancreatic Ductal Adenocarcinoma: A Path Towards Personalized Prognostication.
Javed AA, Habib JR, Andel PCM, Campbell BA, Rompen IF, Mahmud O, Fatimi A, van Goor IWJM, Schouten TJ, Stoop TF, Salinas CH, van Santvoort HC, Koerkam BG, Molenaar IQ, Wolfgang CL, Besselink MG, He J, Daamen LA; Dutch Pancreatic Cancer Group and the PANC-PALS Consortium. Javed AA, et al. Ann Surg. 2025 Feb 7. doi: 10.1097/SLA.0000000000006660. Online ahead of print. Ann Surg. 2025. PMID: 39928537
96 results